Since bleeding,particularly intracranial hemorrhage,and portal vein thrombosis and embolism may complicate exchange transfusions we investigated coagulation during this procedure. Many pediatricians prefer heparinized fresh blood with or without neutralisation of heparin by protamine after exchange transfusion.Others use ACD blood with or without additional heparin.But there is no agreement on the amount of heparin to be substituted.
At our Institution we injected heparin in a dosage of 50 IU / kg body-weight at the beginning and in the middle of exchange transfusion. Fig.! shows two typical curves of thrombin time during exchange transfusion. The longlasting overdosage of heparin is certainly dangerous and makes no therapeutical sense,the fast normqlisation on the other side may leqd to thrombosis of umbilical vein catheter and pulmonary and cerebral embolism. In addition we prefer fresh ACD-blood and add such a quantity of heparin,that in each exchange step the removed equals the reinfused heparin. We assume an effective heparin level of 10 IU / kg and add 50 IU of heparin to 500 ml blood.
It is advisable to check thrombin time during the exchange transfusion,since occasionally the bleeding risk is increased even when applying these low heparin doses.
Systemic heparinization is thought to be especially important during exchange transfusion in new-borns with septicaemia, which is often complicated by disseminated intravascular coagulation.Aggravation of intravascular coagulation may occur,when clotting factors are infused.
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